Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.
Clinical trial NCT05330871 · UNKNOWN
Trial details
- NCT number
- NCT05330871
- Sponsor
- Seventh Medical Center of PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-17
- Primary completion
- 2022-06-30
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.